Laser Treatment for Prostate Enlargement in Patients at Risk of Bleeding
Author Information
Author(s): Yushi Araki, Takashi Kawahara, Teppei Takeshima, Kazuhide Makiyama, Hiroji Uemura
Primary Institution: Yokohama City University Medical Center
Hypothesis
Is contact laser vaporization of the prostate (CVP) safe and effective for benign prostate hyperplasia (BPH) patients with a risk of hemorrhage?
Conclusion
CVP treatment appears to be acceptable for BPH patients with hemorrhagic risk, but close postoperative follow-up is required.
Supporting Evidence
- 93 patients were treated with CVP for BPH.
- Postoperative IPSS scores significantly decreased from 22 to 8.
- 16.1% of patients required temporary catheterization after treatment.
- Two patients experienced late-onset hemorrhage 23 and 26 days postoperatively.
Takeaway
Doctors used a special laser to treat men with prostate problems who might bleed easily, and it worked well without causing too many issues.
Methodology
93 BPH patients underwent CVP treatment, with assessments of urinary symptoms and complications.
Potential Biases
Potential bias due to the retrospective nature and single-center design.
Limitations
The study was retrospective, conducted at a single institution with a small sample size.
Participant Demographics
Median age was 72 years, with 30.1% having a hemorrhage risk.
Statistical Information
P-Value
< 0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website